Max Planck Institute for Infection Biology
The Max Planck Society is Germany’s most successful research organization. Since its establishment in 1948, no fewer than 18 Nobel laureates have emerged from the ranks of its scientists, putting it on a par with the best and most prestigious research institutions worldwide. The Max Planck Institute for Infection Biology was founded in 1993 with Prof. Dr. Dr. h.c. Stefan H.E. Kaufmann as Founding Director. The institute employs multidisciplinary approaches to infection biology comprising concepts and methodologies of molecular genetics, immunology, cell biology, epidemiology, clinical research and protein chemistry. The institute promotes the applications of its research towards paving the way for the design of rational measures to control infectious diseases. The Department of Immunology, at the Max Planck Institute for Infection Biology in Berlin, is the place of origin of VPM1002. Stefan H.E. Kaufmann is advising and supporting the further development of their invention and also performing further research into this vaccine and tuberculosis.